주메뉴 바로가기OUT
본문 바로가기
퀵메뉴 바로가기
마이메뉴 바로가기
도서관 정보 바로가기
링크메뉴
주메뉴
소장자료검색
소장자료
Open API
연속간행물검색
기본검색
A-Z
신착자료검색
비도서검색
전체
DVD
고문헌검색
고문헌검색
송광사 고문헌검색
계당 고문헌 검색
학위논문검색
전자자료 통합검색
통합검색
학술DB
국내학술DB
국외학술DB
e-Journal(AtoZ)
eBook/audioBook
eBook
audioBook
대출반납서비스
이용안내
대출/연장/이력/예약
대출도서순위조회
도서신청서비스
희망도서신청
보존서고자료
서가부재도서
분관대출조회
시설이용서비스
스터디룸예약
일반열람실좌석배치도
장애학생 지원서비스
열람실 이용안내
교내 배달서비스
타기관이용서비스
상호대차/원문복사
타기관열람신청
무인예약대출 서비스
이용안내
신청현황 조회
학위논문파일 제출
학위논문제출안내
학위논문제출
개인정보관리
My Page
나의서재
원문복사 신청/조회
이용안내
검색신청
직접신청
신청리스트
상호대차 신청/조회
이용안내
검색신청
직접신청
신청리스트
연구지원서비스
이용안내
서비스신청
신청내역조회
이용교육서비스
교육안내
교육공지 및 신청
신청내역조회
교육자료실
배달서비스
이용안내
신청내역조회
지정도서신청
이용안내
교수별리스트
교과목별리스트
학과별리스트
교과목신청
교과목신청리스트
지정도서신청
Q&A
논문작성지원
EndNote 이용
Turnitin(논문표절예방)이용
CopyKIller(논문표절예방)
도서관가이드
이용안내
학과가이드
서비스가이드
도서관소개
연혁
규정
역대관장
발전계획
도서관사람들
도서관 통계
찾아오는길
이용안내
개관시간
자료분류체계
자료이용안내
이용자별안내
모바일도서관(APP)
시설안내
본관(홍도)안내
별관(백도)안내
정보마루안내
분관안내
지원시설
도서기증/위탁
도서기증 및 위탁안내
게시판
공지사항
학술공지
신착/신간
질의응답
분실물안내
FAQ
전시마당
이달의 고서
전대愛서52
도서관 Gallery
소장자료검색
연속간행물검색
신착자료검색
비도서검색
고문헌검색
학위논문검색
전자자료 통합검색
학술DB
e-Journal(AtoZ)
eBook/audioBook
대출반납서비스
도서신청서비스
시설이용서비스
장애학생 지원서비스
타기관이용서비스
무인예약대출 서비스
학위논문파일 제출
개인정보관리
원문복사 신청/조회
상호대차 신청/조회
연구지원서비스
이용교육서비스
배달서비스
지정도서신청
논문작성지원
도서관가이드
도서관소개
이용안내
시설안내
도서기증/위탁
게시판
전시마당
소장자료검색
연속간행물검색
신착자료검색
비도서검색
고문헌검색
학위논문검색
전자자료 통합검색
학술DB
e-Journal(AtoZ)
eBook/audioBook
대출반납서비스
도서신청서비스
시설이용서비스
장애학생 지원서비스
타기관이용서비스
무인예약대출 서비스
학위논문파일 제출
개인정보관리
원문복사 신청/조회
상호대차 신청/조회
연구지원서비스
이용교육서비스
배달서비스
지정도서신청
논문작성지원
도서관가이드
도서관소개
이용안내
시설안내
도서기증/위탁
게시판
전시마당
도서관안내
시설안내
정보마루안내
4F
전자자료 상세검색
전자자료 상세검색
전자자료 상세검색
통합검색
소장자료
전자자료
통합검색
키워드
전체
저자
제목
주제어
출처
초록
ISSN
ISBN
결과내 검색
검색어
[키워드: "VATRINET, R"]
총
17
건
※ 중복 레코드가 제거된 검색 결과가 표시됩니다.
1/2
페이지
검색결과수정
검색범위확장
Full Text내 키워드 확장
관련 주제어 확장
재검색
검색결과제한
원문(Full Text)
Peer-Reviewed 학술지
발행년
-
재검색
자료유형
Academic Journals
(16)
Magazines
(1)
주제
ebola vaccines
(4)
hemorrhagic fever, ebola
(4)
ebolavirus
(2)
주제
Count
Name
ebola vaccines
(
4
)
hemorrhagic fever, ebola
(
4
)
ebolavirus
(
2
)
electron transport complex i
(
2
)
acetoacetates
(
1
)
adenoma, oxyphilic
(
1
)
aminopyridines
(
1
)
antineoplastic agents
(
1
)
chondrocytes
(
1
)
covid-19
(
1
)
dna-binding proteins
(
1
)
energy metabolism
(
1
)
hypoxia-inducible factor 1, alpha subunit
(
1
)
kruppel-like transcription factors
(
1
)
lithium
(
1
)
metformin
(
1
)
mitochondria
(
1
)
neoplasms
(
1
)
osteoarthritis
(
1
)
pyrroles
(
1
)
repressor proteins
(
1
)
닫기
간행물
toxicon x
(2)
trials
(2)
american journal of tropical medicine and hygiene
(1)
간행물
Count
Name
toxicon x
(
2
)
trials
(
2
)
american journal of tropical medicine and hygiene
(
1
)
cancer metabolism
(
1
)
international journal of biochemistry cell biology
(
1
)
international journal of molecular sciences
(
1
)
lancet global health
(
1
)
mediators of inflammation
(
1
)
nature communications
(
1
)
new england journal of medicine
(
1
)
oncotarget
(
1
)
revue d epidemiologie et de sante publique
(
1
)
revue d'epidemiologie et de sante publique
(
1
)
the lancet global health
(
1
)
vaccine
(
1
)
닫기
출판사
elsevier ltd
(4)
biomed central
(3)
american society of tropical medicine and hygiene
(1)
출판사
Count
Name
elsevier ltd
(
4
)
biomed central
(
3
)
american society of tropical medicine and hygiene
(
1
)
elsevier
(
1
)
elsevier masson sas
(
1
)
elsevier science
(
1
)
hindawi pub. corp
(
1
)
impact journals
(
1
)
massachusetts medical society
(
1
)
mdpi
(
1
)
nature pub. group
(
1
)
닫기
언어
english
(15)
french
(1)
수록데이터베이스
MEDLINE
(14)
ScienceDirect
(2)
Supplemental Index
(1)
PQDT
CAJ
RISS
PsycINFO
전체선택
날짜 내림차순
날짜 오름차순
연관도
10
20
30
50
1
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone
학술저널
issue
In
The Lancet Global Health
November 2023 11(11):e1743-e1752
Author
Mooney, T
Conteh, L
Bangura, MS
Bangura, MA
Jalloh, H
Kamara, I
Kamara, M
Koroma, S
Sesay, M
Sesay, MT
Deen, AT
Kamara, A
Kamara, EL
Kamara, SLM
Koroma, AH
Mansaray, IS
Massaquoi, MJ
Nabie, A
Kowuor, D
Njie, Y
Odeny, L
Sheku, M
Jalloh, AB
Sow, A
Swaray, E
Mansaray, F
Sessie, T
Sunders, J-HC
Turay, SI-S
Weekes, J
Pessima, M
Wurie, A
Conteh, M
Jalloh, MI
Kamara, PBD
Kanneh, DP
Kanneh, M
Komeh, I
Koroma, M
Kuyateh, M
Mansaray, FF
Leigh, B
Watson-Jones, D
Samai, M
Deen, GF
Sesay, T
Piot, P
Greenwood, B
Lees, S
Larson, H
Afolabi, M
Ishola, D
Baiden, F
Faye, F
Tindanbil, D
Kamara, MM
Swaray, IB
Bangura, A
Kamara, AB
Morovia, FE
Kallon, JA
Murray, M
Sesay, F
Suma, F
Sesay, IG
Choi, EM
Manno, D
Foster, J
Rwezaula,
R
Akhigbe, I
Adetola, H
Kamara, B
Lowe, B
Lawal, B
Kohn, B
Tuda, GO
Koroma, F
Bangura, G
Kroma, MT
Fofanah, L
Pessima, A
Rogers, M
Sheriff, O
Fangawa, J
Foday, S
Jabbie, I
Mansaray, HA
Sesay, K
Jakema, HB
Sheku, MF
Jalloh, KFN
Kabba, M
Kanjie, F
Kanu, AP
Kassa-Koroma, G
Jusu, M
Koroma, B
Borboh, P
Kallon, A
van Roey, K
Conteh, P
Samura, M
Gandie, V
Marrah, M
Kalokoh, J
Bangura, MI
Connor, N
Saidu, S
Turay, AS
Lahai, A
Johnson, CL
Kogba, DB
Vincent, W
Bangura, M
Tengbeh, A
Bangura, K
Kabia,
R
Nyakoi, AM
Lee, S
Nyaberi, D
Ndingi, S
Nyallay, L
Bangura, AR
Idriss, B
Sillah, M
Mackay, W
Murray, T
Edem-Hotah, J
Fatorma, T
Bangura, S
Bonnie, E
Sannoh, M
Malcolm, S
Brown, J
Snowden, E
Howard, K
Ojugo, A
Massin-Shepherd, C
BEAVOGUI, AH
KEITA, CM
CAMARA, OK
GUILAVOGUI, JPY
BAH, H
SAMOURA, MA
MUAMBA, D
SEMAKUBA, B
CAMARA, AK
KABA, AS
BERERD-CAMARA, M
YARADOUNO, M
DECHENAUD, M
CAMARA, MT
TAMBALOU, J
HABA, M
DIALLO, SD
THEA, A
DOUMBOUYA, N
FOFANA, ML
BEAVOGUI, M
CAMARA, AA
BEAVOGUI, JT
DIOUF, W
AUGIER, A
BARTE DE SAINTE FARE, E
SIVAHERA MUYISA, B
SANI, S
VATRINET
,
R
HAMZE, B
LACARRA, B
D’ORTENZIO, E
ALE, B
BETARD, C
RICHERT, L
OULAI, D
KANTE, M
SOUTTHIPHONG, A-A
SCHWIMMER, C
THIÉBAUT,
R
OTTAVI, A
COUFFIN-CADIERGUES, S
ESPEROU, H
Chai, SP
Buth, W
Offergeld, K
Menten, A
Hammoud, N
De Ridder, S
Sellecchia,
R
in ’t Veld,
R
Fogap, N
Anumendem, D
Stapleton, H
Reijns, T
Haydon, J
Roza, L
Sawyer, B
Hoda, S
Yee, J
De Cnodder, T
Hubin, E
Telen, L
Desai, J
Bennet, M
Pawlowski, M
van Gils, N
Boeykens, N
Kwasniak, A
Ligthart, M
Van Roey, G
Fernandez, E
Gaddah, A
van Dijck, W
Jingshuang, S
Randrasana, S
Artis, C
Akinbinu, A
Poretti, A
Van Ballaert, S
Harris, M
Van Looveren, M
Brandt, P
Robinson, C
Bockstal, V
McLean, C
Versteege, I
Ferrault, C
Kaminski, A
Vergauwen, H
Kerama, CI
Forcheh, CA
DiMondi, CV
Stewart, L
Meurer, J
Beounitis, A
Peeters, J
Su, C
Keshinro, B
Delport, C
Sharkie, E
Zhang, J
Du, C
Hu, K
Strydom, A
Bezem-Aviv, I
Wachnicka, A
Kumar, P
Cheng, S
Kang, K
Choi, Edward Man-Lik
*
Lacarra, Boris
Afolabi, Muhammed O
Ale, Boni Maxime
Baiden, Frank
Bétard, Christine
Foster, Julie
Hamzé, Benjamin
Schwimmer, Christine
Manno, Daniela
D’Ortenzio, Eric
Ishola, David
Keita, Cheick Mohamed
Keshinro, Babajide
Njie, Yusupha
van Dijck, Wim
Gaddah, Auguste
Anumendem, Dickson
Lowe, Brett
Vatrinet
, Renaud
Lawal, Bolarinde Joseph
Otieno, Godfrey T
Samai, Mohamed
Deen, Gibrilla Fadlu
Swaray, Ibrahim Bob
Kamara, Abu Bakarr
Kamara, Michael Morlai
Diagne, Mame Aminata
Kowuor, Dickens
McLean, Chelsea
Leigh, Bailah
Beavogui, Abdoul Habib
Leyssen, Maarten
Luhn, Kerstin
Robinson, Cynthia
Douoguih, Macaya
Greenwood, Brian
Thiébaut, Rodolphe
Watson-Jones, Deborah
DB Label
Database : ScienceDirect
원문보기
Full Text (Clinical Key)
Full Text (ScienceDirect O/A)
등재 - SCOPUS
조회 - Impact Factor (JCR)
등재 - Web of Science (SCIE)
2
Gestion en temps réel d’une base de données biologiques centralisée pour un essai clinique vaccinal de phase II multicentrique en Afrique
학술저널
issue
In
Revue d'Epidemiologie et de Santé Publique
May 2019 67 Supplement 3:S129-S129
Author
Campion, C.
Vatrinet
,
R
.
Bererd Camara, M.
McCullough, J.
Awuondo, K.
Sarro, Y.
Lhomme, E.
Richert, L.
DB Label
Database : ScienceDirect
원문보기
등재 - SCOPUS
조회 - Impact Factor (JCR)
등재 - Web of Science (SCIE)
3
Perceptions, attitudes, and willingness of healthcare and frontline workers to participate in an Ebola vaccine trial in Uganda.
학술저널
issue
Vaccine
[Vaccine] 2024 Apr 30; Vol. 42 (12), pp. 3002-3008.
Date of Electronic Publication:
2024 Apr 01.
Author
Kimbugwe G
; MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda. Electronic address: geofrey.kimbugwe@mrcuganda.org.
Vatrinet
R
; Epicentre Paris, Department of Research, Paris, France.
Mwanga JA
; Epicentre Mbarara, Uganda.
Kakuru
R
; Epicentre Mbarara, Uganda.
Mpeirwe D
; Epicentre Mbarara, Uganda.
Logoose S
; Epicentre Mbarara, Uganda.
Opio K
; Epicentre Mbarara, Uganda.
Kambale M
; Epicentre Mbarara, Uganda.
Seeley J
; MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda; London School of Hygiene and Tropical Medicine, London, United Kingdom.
Grais RF
; Epicentre Paris, Department of Research, Paris, France.
Marquer C
; Epicentre Paris, Department of Research, Paris, France.
Kaleebu P
; MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda; Uganda Virus Research Institute, Entebbe, Uganda; London School of Hygiene and Tropical Medicine, London, United Kingdom.
Ssali A
; MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda; London School of Hygiene and Tropical Medicine, London, United Kingdom.
DB Label
Database : MEDLINE
원문보기
Full Text (ScienceDirect)
Full Text (Clinical Key)
조회 - Impact Factor (JCR)
등재 - Web of Science (SCIE)
4
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone.
학술저널
issue
The Lancet. Global health
[Lancet Glob Health] 2023 Nov; Vol. 11 (11), pp. e1743-e1752.
Author
Choi EM
; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK. Electronic address: edward.choi@lshtm.ac.uk.
Lacarra B
; REACTing Unit, Inserm, Paris, France.
Afolabi MO
; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK; EBOVAC-Salone Project, Kambia, Sierra Leone.
Ale BM
; Clinical Investigation Center-Clinical Epidemiology, University of Bordeaux, Inserm, Institut Bergonié, EUCLID/F-CRIN CIC-EC1401, Bordeaux, France.
Baiden F
; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK; EBOVAC-Salone Project, Kambia, Sierra Leone.
Bétard C
; Clinical Investigation Center-Clinical Epidemiology, University of Bordeaux, Inserm, Institut Bergonié, EUCLID/F-CRIN CIC-EC1401, Bordeaux, France.
Foster J
; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.
Hamzé B
; Pôle Recherche Clinique, Inserm, Paris, France.
Schwimmer C
; Clinical Investigation Center-Clinical Epidemiology, University of Bordeaux, Inserm, Institut Bergonié, EUCLID/F-CRIN CIC-EC1401, Bordeaux, France; Department of Medical Information, Centre Hospitalier Universitaire (CHU) de Bordeaux, EUCLID/F-CRIN CIC-EC1401, Inserm, Institut Bergonié, Bordeaux, France.
Manno D
; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.
D'Ortenzio E
; ANRS, Maladies infectieuses émergentes, Inserm, Paris, France.
Ishola D
; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK; EBOVAC-Salone Project, Kambia, Sierra Leone.
Keita CM
; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Forécariah, Guinea.
Keshinro B
; Janssen Vaccines & Prevention, Leiden, Netherlands.
Njie Y
; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK; EBOVAC-Salone Project, Kambia, Sierra Leone.
van Dijck W
; Janssen Research & Development, Beerse, Belgium.
Gaddah A
; Janssen Research & Development, Beerse, Belgium.
Anumendem D
; Janssen Research & Development, Beerse, Belgium.
Lowe B
; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.
Vatrinet
R
; REACTing Unit, Inserm, Paris, France.
Lawal BJ
; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK; EBOVAC-Salone Project, Kambia, Sierra Leone.
Otieno GT
; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK; EBOVAC-Salone Project, Kambia, Sierra Leone.
Samai M
; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
Deen GF
; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
Swaray IB
; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
Kamara AB
; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
Kamara MM
; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.
Diagne MA
; Laboratoire de Sociologie, Anthropologie et Psychologie Sociale, Department of Sociology, Université Cheikh Anta Diop de Dakar, Dakar, Senegal.
Kowuor D
; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.
McLean C
; Janssen Vaccines & Prevention, Leiden, Netherlands.
Leigh B
; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
Beavogui AH
; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Forécariah, Guinea.
Leyssen M
; Janssen Vaccines & Prevention, Leiden, Netherlands.
Luhn K
; Janssen Vaccines & Prevention, Leiden, Netherlands.
Robinson C
; Janssen Vaccines & Prevention, Leiden, Netherlands.
Douoguih M
; Janssen Vaccines & Prevention, Leiden, Netherlands.
Greenwood B
; Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK.
Thiébaut
R
; Clinical Investigation Center-Clinical Epidemiology, University of Bordeaux, Inserm, Institut Bergonié, EUCLID/F-CRIN CIC-EC1401, Bordeaux, France; Department of Medical Information, Centre Hospitalier Universitaire (CHU) de Bordeaux, EUCLID/F-CRIN CIC-EC1401, Inserm, Institut Bergonié, Bordeaux, France.
Watson-Jones D
; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania.
DB Label
Database : MEDLINE
원문보기
Full Text (Clinical Key)
Full Text (ScienceDirect O/A)
등재 - SCOPUS
조회 - Impact Factor (JCR)
등재 - Web of Science (SCIE)
5
Reflections on Participation in a Trial on Hydroxychloroquine as Prevention for COVID-19 among Health Workers in Niger.
학술저널
issue
The American journal of tropical medicine and hygiene
[Am J Trop Med Hyg] 2023 Aug 14; Vol. 109 (3), pp. 511-514.
Date of Electronic Publication:
2023 Aug 14 (
Print Publication:
2023).
Author
Kabore Y
; Epicentre Niger, Niamey, Niger.
Vatrinet
R
; Research Department, Epicentre Paris, Paris, France.
Guindo O
; Epicentre Niger, Niamey, Niger.
Moussa SH
; Service de Pneumologie, Hôpital National Amirou Boubacar Diallo (Lamorde), Niamey, Niger.
Schilling WHK
; Centre for Tropical Medicine & Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Grais RF
; Research Department, Epicentre Paris, Paris, France.
DB Label
Database : MEDLINE
원문보기
조회 - Impact Factor (JCR)
등재 - Web of Science (SCIE)
6
Randomized Trial of Vaccines for Zaire Ebola Virus Disease.
학술저널
issue
The New England journal of medicine
[N Engl J Med] 2022 Dec 29; Vol. 387 (26), pp. 2411-2424.
Date of Electronic Publication:
2022 Dec 14.
Author
Kieh M
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Richert L
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Beavogui AH
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Grund B
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Leigh B
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
D'Ortenzio E
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Doumbia S
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Lhomme E
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Sow S
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Vatrinet
R
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Roy C
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Kennedy SB
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Faye S
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Lees S
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Millimouno NP
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Camara AM
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Samai M
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Deen GF
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Doumbia M
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Espérou H
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Pierson J
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Watson-Jones D
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Diallo A
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Wentworth D
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
McLean C
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Simon J
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Wiedemann A
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Dighero-Kemp B
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Hensley L
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Lane HC
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Levy Y
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Piot P
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Greenwood B
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Chêne G
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Neaton J
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
Yazdanpanah Y
; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.
R
., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.
R
., E.L., C.
R
., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.
R
., E.L., C.
R
., G.C.), INSERM (E.D.,
R
.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).
DB Label
Database : MEDLINE
원문보기
등재 - SCOPUS
조회 - Impact Factor (JCR)
등재 - Web of Science (SCIE)
7
Corrigendum to "Snakebite envenoming in humanitarian crises and migration: A scoping review and the Médecins Sans Frontières experience" [Toxicon: X 13 (March 2022) 100089].
issue
Toxicon: X
[Toxicon X] 2022 Jul 12; Vol. 15, pp. 100132.
Date of Electronic Publication:
2022 Jul 12 (
Print Publication:
2022).
Author
Alcoba G
; Médecins Sans Frontières, Operational Center Geneva, Geneva, Switzerland.; Division of Tropical and Humanitarian Medicine, Geneva University Hospitals, Geneva, Switzerland.
Potet J
; Médecins Sans Frontières, Access Campaign, Paris, France.
Vatrinet
R
; Médecins Sans Frontières, Epicentre, Paris, France.
Singh S
; Médecins Sans Frontières, Operational Center Paris, Paris, France.
Nanclares C
; Médecins Sans Frontières, Operational Center Barcelona, Barcelona, Spain.
Kruse A
; Médecins Sans Frontières, Operational Center Brussels, Brussels, Belgium.
Den Boer M
; Médecins Sans Frontières, Manson Unit, London, United Kingdom.
Molfino L
; Médecins Sans Frontières, Operational Center Geneva, Geneva, Switzerland.
Ritmeijer K
; Médecins Sans Frontières, Operational Center Amsterdam, Amsterdam, the Netherlands.
DB Label
Database : MEDLINE
원문보기
Open Access (PubMed Central)
Full Text (ScienceDirect O/A)
등재 - SCOPUS
8
Snakebite envenoming in humanitarian crises and migration: A scoping review and the Médecins Sans Frontières experience.
학술저널
issue
Toxicon: X
[Toxicon X] 2021 Dec 18; Vol. 13, pp. 100089.
Date of Electronic Publication:
2021 Dec 18 (
Print Publication:
2022).
Author
Alcoba G
; Médecins Sans Frontières, Operational Center Geneva, Geneva, Switzerland.; Division of Tropical and Humanitarian Medicine, Geneva University Hospitals , Geneva, Switzerland.
Potet J
; Médecins Sans Frontières, Access Campaign, Paris, France.
Vatrinet
R
; Médecins Sans Frontières, Epicentre, Paris, France.
Singh S
; Médecins Sans Frontières, Operational Center Paris, Paris, France.
Nanclares C
; Médecins Sans Frontières, Operational Center Barcelona, Barcelona, Spain.
Kruse A
; Médecins Sans Frontières, Operational Center Brussels, Brussels, Belgium.
Den Boer M
; Médecins Sans Frontières, Manson Unit, London, United Kingdom.
Molfino L
; Médecins Sans Frontières, Operational Center Geneva, Geneva, Switzerland.
Ritmeijer K
; Médecins Sans Frontières, Operational Center Amsterdam, Amsterdam, the Netherlands.
DB Label
Database : MEDLINE
원문보기
Open Access (PubMed Central)
Full Text (ScienceDirect O/A)
등재 - SCOPUS
9
Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.
issue
Trials
[Trials] 2021 Sep 01; Vol. 22 (1), pp. 583.
Date of Electronic Publication:
2021 Sep 01.
Author
Badio M
; Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
Lhomme E
; Univ. Bordeaux, Inserm, Bordeaux Population Health Research, Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.
Kieh M
; Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
Beavogui AH
; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Mafèrinyah, Guinea.
Kennedy SB
; Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
Doumbia S
; University of Sciences, Technique and Technology of Bamako, Bamako, Mali.
Leigh B
; College of Medicine and Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone.
Sow SO
; Centre pour le Développement des Vaccins, Bamako, Mali.
Diallo A
; INSERM, Pôle de Recherche Clinique, 75013, Paris, France.
Fusco D
; INSERM, Pôle de Recherche Clinique, 75013, Paris, France.
Kirchoff M
; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Termote M
; Univ. Bordeaux, Inserm, Bordeaux Population Health Research, Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.
Vatrinet
R
; REACTing, Institut Thématique Immunologie, Inflammation, Infectiologie et Microbiologie, Inserm, Paris, France.
Wentworth D
; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
Esperou H
; INSERM, Pôle de Recherche Clinique, 75013, Paris, France.
Lane HC
; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Pierson J
; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Watson-Jones D
; London School of Hygiene & Tropical Medicine, London, UK.
Roy C
; Univ. Bordeaux, Inserm, Bordeaux Population Health Research, Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.
D'Ortenzio E
; REACTing, Institut Thématique Immunologie, Inflammation, Infectiologie et Microbiologie, Inserm, Paris, France.; AP-HP, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales, F-75018, Paris, France.
Greenwood B
; London School of Hygiene & Tropical Medicine, London, UK.
Chêne G
; Univ. Bordeaux, Inserm, Bordeaux Population Health Research, Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.
Richer L
; Univ. Bordeaux, Inserm, Bordeaux Population Health Research, Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.
Neaton JD
; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
Yazdanpanah Y
; REACTing, Institut Thématique Immunologie, Inflammation, Infectiologie et Microbiologie, Inserm, Paris, France. yazdan.yazdanpanah@aphp.fr.; AP-HP, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales, F-75018, Paris, France. yazdan.yazdanpanah@aphp.fr.
DB Label
Database : MEDLINE
원문보기
Full Text (원문보기)
Full Text (원문보기)
Open Access (PubMed Central)
Open Access (BioMed Central)
OA (Springer)
등재 - SCOPUS
조회 - Impact Factor (JCR)
등재 - Web of Science (SCIE)
10
Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.
학술저널
issue
Trials
[Trials] 2021 Jan 23; Vol. 22 (1), pp. 86.
Date of Electronic Publication:
2021 Jan 23.
Author
Badio M
; Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
Lhomme E
; Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.
Kieh M
; Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
Beavogui AH
; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Mafèrinyah, Guinea.
Kennedy SB
; Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
Doumbia S
; University of Sciences, Technique and Technology of Bamako, Bamako, Mali.
Leigh B
; College of Medicine and Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone.
Sow SO
; Centre pour le Développement des Vaccins, Bamako, Mali.
Diallo A
; INSERM, Pôle de Recherche Clinique, 75013, Paris, France.
Fusco D
; INSERM, Pôle de Recherche Clinique, 75013, Paris, France.
Kirchoff M
; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Termote M
; Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.
Vatrinet
R
; REACTing, Institut Thématique Immunologie, Inflammation, Infectiologie et Microbiologie, Inserm, Paris, France.
Wentworth D
; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
Esperou H
; INSERM, Pôle de Recherche Clinique, 75013, Paris, France.
Lane HC
; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Pierson J
; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Watson-Jones D
; London School of Hygiene & Tropical Medicine, London, UK.
Roy C
; Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
D'Ortenzio E
; REACTing, Institut Thématique Immunologie, Inflammation, Infectiologie et Microbiologie, Inserm, Paris, France.; AP-HP, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales, F-75018, Paris, France.
Greenwood B
; London School of Hygiene & Tropical Medicine, London, UK.
Chêne G
; Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
Richert L
; Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
Neaton JD
; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
Yazdanpanah Y
; REACTing, Institut Thématique Immunologie, Inflammation, Infectiologie et Microbiologie, Inserm, Paris, France. yazdan.yazdanpanah@aphp.fr.; AP-HP, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales, F-75018, Paris, France. yazdan.yazdanpanah@aphp.fr.
DB Label
Database : MEDLINE
원문보기
Full Text (원문보기)
Full Text (원문보기)
Open Access (PubMed Central)
Open Access (BioMed Central)
OA (Springer)
등재 - SCOPUS
조회 - Impact Factor (JCR)
등재 - Web of Science (SCIE)
1
2
바구니보기
82463
129856282
대학도서관
RISS-한국교육학술정보원
LG 상남도서관
가톨릭대학교 도서관
강남대학교 도서관
강릉대학교 도서관
강원대학교 삼척캠퍼스 도서관
강원대학교 중앙도서관
건국대학교 상허기념도서관
경기대학교 중앙도서관
경남과학기술대학교 도서관
경남대학교 중앙도서관
경북대학교 도서관
경상대학교 중앙도서관
경성대학교 중앙도서관
경인교육대학교 도서관
경희대학교 도서관
계명대학교 동산도서관
고려대학교 중앙도서관
고신대학교 중앙도서관
공주교육대학교 디지털도서관
공주대학교 중앙도서관
관동대학교 중앙도서관
광운대학교 중앙도서관
광주과학기술원 도서관
광주교육대학교 디지털도서관
광주대학교 중앙도서관
국가전자도서관
국립중앙도서관
국민대학교 성곡도서관
국회도서관
군산대학교 중앙도서관
금오공과대학교 도서관
남서울대학교 중앙도서관
단국대학교 율곡기념도서관
단국대학교 퇴계기념중앙도서관
대구가톨릭대학교 중앙도서관
덕성여자대학교 중앙도서관
동국대학교 도서관
동덕여자대학교 중앙도서관
동신대학교 중앙도서관
동아대학교 중앙도서관
동의대학교 중앙도서관
명지대학교 도서관
목원대학교 중앙도서관
목포대학교 중앙도서관
배재대학교 중앙도서관
부경대학교 도서관
부산교육대학교 학술정보관
부산대학교 도서관
부산외국어대학교 도서관
삼육대학교 도서관
상명대학교 중앙도서관
상지대학교 학술정보원
서강대학교 로욜라도서관
서울과학기술대학교 도서관
서울교육대학교 디지털도서관
서울대학교 농학도서관
서울대학교 사회과학도서관
서울대학교 중앙도서관
서울시립대학교 중앙도서관
서울신학대학교 도서관
서울여자대학교 중앙도서관
서원대학교 학술정보원
성결대학교 학술정보관
성공회대학교 중앙도서관
성균관대학교 학술정보관
성신여자대학교 중앙도서관
세종대학교 학술정보원
송원대학교
수리과학연구정보센터
수원대학교 중앙도서관
숙명여자대학교 도서관
순천대학교 중앙도서관
순천향대학교 향설기념 중앙도서관
숭실대학교 중앙도서관
신라대학교 도서관
아주대학교 중앙도서관
안동대학교 중앙도서관
연세대학교 의학도서관
연세대학교 학술정보원
영남대학교 중앙도서관
영동대학교 중앙도서관
우석대학교 중앙도서관
울산대학교 중앙도서관
원광대학교 중앙도서관
월계문화정보도서관
위덕대학교 회당학술정보원
이화여자대학교 중앙도서관
인덕대학 도서관
인제대학교 백인제기념도서관
인천대학교 학산도서관
인하대학교 정석학술정보관
장로회신학대학교 도서관
전남대학교 여수캠퍼스 도서관
전북대학교 중앙도서관
전주교육대학교 디지털도서관
전주대학교 중앙도서관
제주대학교 중앙도서관
조선대학교 중앙도서관
중앙대학교 서울캠퍼스 중앙도서관
중앙대학교 안성캠퍼스 중앙도서관
진주교육대학교 도서관
창원대학교 중앙도서관
청주대학교 중앙도서관
추계예술대학교 전자정보도서관
충남대학교 디지털도서관
충북대학교 도서관
포항공과대학교 청암학술정보관
한국과학기술원 전자도서관
한국교원대학교 도서관
한국기술교육대학교 다산정보관
한국외국어대학교 도서관
한국체육대학교 학술정보시스템
한국해양대학교 도서관
한남대학교 학술정보관
한동대학교 학술정보관
한림대학교 일송기념도서관
한밭대학교 도서관
한서대학교 중앙도서관
한성대학교 학술정보관
한양대학교 백남학술정보관
한양대학교 안산학술정보관
호남대학교 중앙도서관
홍익대학교 중앙도서관
화순전남대병원의학도서실
참고정보원
RISS-한국교육학술정보원
NDSL 과학기술정보통합서비스
건설연구정보센터(서울대학교)
과학기술정책연구원(STEPI)
광주과학기술원(K-JIST)
국내의학학술지 초록검색
기계공학연구정보센터(부산대학교)
농생명과학연구정보센터(서울대학교)
대외경제정책연구원(KIEP)
물리학연구정보센터(서울대학교)
보건연구정보센터(전남대학교)
생물학연구정보센터(포항공과대학교)
의약연구정보센터(숙명여자대학교)
의학연구정보센터(충북대학교)
재료연구정보센터(경북대학교)
테크노경영연구정보센터
한국과학기술연구원(KIST)
한국과학기술원(KAIST)
한국과학기술정보연구원(KISTI)
한국교육개발원(KEDI)
한국기계연구원(KIMM)
한국기초과학지원연구원(KBSI)
한국문화예술진흥원(KCAF)
한국생명공학연구원(KRIBB)
한국에너지기술연구원(KIER)
한국원자력연구원(KAERI)
한국전기연구원(KERI)
한국전자통신연구원(ETRI)
한국지질자원연구원(KIGAM)
한국표준과학연구원(KRISS)
한국항공우주연구원(KARI)
한국해양연구원(KORDI)
한국화학연구원(KRICT)
한국환경정책평가연구원
화학공학연구정보센터(고려대학교)
환경지질연구정보센터(연세대학교)